HVEM gene expression is proposed to be a promising prognostic marker in metastatic melanomas when expressed on melanoma cells to interact with BTLA on tumor-infiltrating lymphocytes (TILs) [11]. The gene discussed is TNFRSF14; the disease is neoplasm.